ATE362481T1 - Lantibiotikum - Google Patents

Lantibiotikum

Info

Publication number
ATE362481T1
ATE362481T1 AT00970338T AT00970338T ATE362481T1 AT E362481 T1 ATE362481 T1 AT E362481T1 AT 00970338 T AT00970338 T AT 00970338T AT 00970338 T AT00970338 T AT 00970338T AT E362481 T1 ATE362481 T1 AT E362481T1
Authority
AT
Austria
Prior art keywords
salivaricin
lantibiotics
applications
bacteriocidal
pyogenes
Prior art date
Application number
AT00970338T
Other languages
English (en)
Inventor
John Tagg
Karen Dierksen
Mathew Upton
Original Assignee
Blis Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blis Technologies Ltd filed Critical Blis Technologies Ltd
Application granted granted Critical
Publication of ATE362481T1 publication Critical patent/ATE362481T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00970338T 1999-10-12 2000-10-12 Lantibiotikum ATE362481T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ50026199 1999-10-12

Publications (1)

Publication Number Publication Date
ATE362481T1 true ATE362481T1 (de) 2007-06-15

Family

ID=19927569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00970338T ATE362481T1 (de) 1999-10-12 2000-10-12 Lantibiotikum

Country Status (15)

Country Link
US (2) US6773912B1 (de)
EP (1) EP1169340B1 (de)
JP (1) JP3673497B2 (de)
AT (1) ATE362481T1 (de)
AU (1) AU772224B2 (de)
BR (1) BR0014740A (de)
CA (1) CA2363713C (de)
DE (1) DE60034879T8 (de)
DK (1) DK1169340T3 (de)
ES (1) ES2286038T3 (de)
HK (1) HK1039622B (de)
NO (1) NO326899B1 (de)
PL (1) PL206441B1 (de)
RU (1) RU2279481C2 (de)
WO (1) WO2001027143A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1483366B1 (de) * 2002-02-22 2010-04-14 Blis Technologies Limited Antimikrobielle zusammensetzung
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
WO2004072272A1 (en) * 2003-02-14 2004-08-26 Blis Technologies Limited Bacterial compositions
DK1653982T3 (en) * 2003-07-18 2019-01-14 Blis Tech Limited TREATMENT OF HALITOSIS
EP1730180A4 (de) * 2004-02-24 2008-06-18 Commw Scient Ind Res Org Gegen pilze wirkende peptide
WO2007070518A2 (en) * 2005-12-13 2007-06-21 The Trustees Of The University Of Pennsylvania Bacteria-derived blis for treatment of acne
FR2905268B1 (fr) * 2006-09-01 2009-01-23 Unither Dev Soc Par Actions Si Substitut salivaire
RU2441915C9 (ru) * 2007-08-03 2012-06-20 Сентинелла Фармасьютикалс, Инк. Гены и белки для биосинтеза лантибиотика 107891
GB0921995D0 (en) * 2009-12-17 2010-02-03 Univ Manchester Antimicrobial peptides
ES2573729T3 (es) * 2010-04-07 2016-06-09 D.M.G. Italia Srl Utilización del Streptococcus salivarius en el tratamiento de infecciones crónicas del tracto respiratorio
DE102012203547A1 (de) * 2012-03-07 2013-09-12 Robert Bosch Gesellschaft Für Medizinische Forschung Mbh Antimikrobielle Peptide
CA2783414A1 (en) * 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition
CN104398537A (zh) * 2014-11-17 2015-03-11 南京灿辰微生物科技有限公司 一种口腔益生菌组合物
CN111227035A (zh) * 2018-11-28 2020-06-05 内蒙古伊利实业集团股份有限公司 一种含益生菌组合物的发酵乳及其制备方法
CN112391305B (zh) * 2019-08-15 2023-01-13 上海交通大学 唾液链球菌f286及其用途
WO2023053073A1 (en) * 2021-09-30 2023-04-06 Blis Technologies Limited Probiotic enhancers and uses thereof
CN117304334A (zh) * 2023-04-25 2023-12-29 大连医科大学 一种唾液链球菌抗菌肽及其制备方法和应用
WO2025132965A1 (en) 2023-12-21 2025-06-26 Reichardt Elisabeth Formulations and devices comprising lantibiotic-producing bacteria

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925160A (en) 1974-09-26 1975-12-09 Univ Creighton Method of producing an antibiotic
JPS615022A (ja) * 1984-06-19 1986-01-10 Advance Res & Dev Co Ltd 腸内細菌叢改善剤
SE463349B (sv) 1989-02-15 1990-11-12 Grahn Eva E Farmaceutiskt preparat foer profylax mot och/eller behandling av beta-streptokockinducerad tonsillit
JPH054927A (ja) * 1991-06-28 1993-01-14 Aizo Matsushiro 乳酸菌含有組成物及びその製造方法
US5872001A (en) 1994-04-20 1999-02-16 Uab Research Foundation Lanthionine antibiotic compositions and methods

Also Published As

Publication number Publication date
NO20013905D0 (no) 2001-08-10
US6773912B1 (en) 2004-08-10
JP3673497B2 (ja) 2005-07-20
NO326899B1 (no) 2009-03-16
JP2003516123A (ja) 2003-05-13
AU7973700A (en) 2001-04-23
ES2286038T3 (es) 2007-12-01
NO20013905L (no) 2001-10-10
DE60034879D1 (en) 2007-06-28
AU772224B2 (en) 2004-04-22
BR0014740A (pt) 2002-06-18
DE60034879T8 (de) 2008-07-03
CA2363713A1 (en) 2001-04-19
HK1039622A1 (en) 2002-05-03
CA2363713C (en) 2007-11-06
US20040232205A1 (en) 2004-11-25
PL364771A1 (en) 2004-12-13
EP1169340B1 (de) 2007-05-16
WO2001027143A1 (en) 2001-04-19
DE60034879T2 (de) 2008-02-07
DK1169340T3 (da) 2007-09-24
EP1169340A4 (de) 2005-06-08
PL206441B1 (pl) 2010-08-31
RU2279481C2 (ru) 2006-07-10
HK1039622B (en) 2007-10-18
EP1169340A1 (de) 2002-01-09

Similar Documents

Publication Publication Date Title
ATE362481T1 (de) Lantibiotikum
CY1110914T1 (el) Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
ZA200202306B (en) Topical treatment of streptococcal infections.
YU91603A (sh) Kristalni oblici azitromicina
DE60113851D1 (de) Bakteriophage mit breitem wirtspektrum
DE60226724D1 (de) Antimikrobielles polypeptid
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
TR200201484T2 (tr) Çeşitli hastalıkların koruyucu ve iyileştirici tedavisi için bakteriyel fajlar ile ilişkili lisleme enzimlerinin kullanımı
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
MA28613B1 (fr) Macrocycles d'amide antibacteriens
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
BR9807523A (pt) Quinoxalinas em combinação tripla com inibidores da protease e inibidores de transcriptase reversa como medicamentos para o tratamento de aids.
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
WO2000058475A3 (en) Streptococcus pneumoniae antigens
ATE259654T1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
UY26763A1 (es) Inmunización del ganado lacteo con proteína gapc quimérica contra infección por estreptococo.
DK1343896T3 (da) Lille syreoplöseligt sporeprotein og anvendelser deraf
CY1105343T1 (el) Σταφυλοκοκκικη πρωτεϊνη αναστολης του χημειοτακτισμου (chips) και η χρηση αυτης
ATE301194T1 (de) Beta-defensine
PT1276495E (pt) Utilizacao de tensioactivo pulmonar recombinante para o tratamento precoce de doencas pulmonares agudas
UY26764A1 (es) Inmunización del ganado lacteo con proteína gapc contra infección por estreptococo.
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
BR0309569A (pt) Vacinas em combinação que incluem polipeptìdeos imunogênicos de fator camp e gapc
ATE452191T1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties